ALERT: Please be vigilant on email and phone, we have been made aware that our speakers are being approached by a scam company (Traveller Point, E Hotel Services or similar) regarding accommodation for a Fusion conference. In the event you are contacted by these companies, please hang up immediately or delete the email. Please note, accommodation is included within your registration fee. You can check and amend your accommodation details via your Fusion account or email admin@fusion-conferences.com.

Registration deadlines

Early Bird - Expired

Talk Submission - 06 Feb 2023

Poster Submission - 07 Apr 2023

Registration Deadline - 07 Apr 2023

Register

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Synopsis

If you are interested in this meeting but not yet ready to register, you can sign up for updates here and our team will keep you updated regarding deadline reminders and grant opportunities relating to this meeting only. 

Breast cancer is now the most common cancer diagnosis worldwide.   Most breast cancers are defined by and driven by the Estrogen Receptor (ER) transcriptional pathway and new insight into how ER mediates gene expression has identified novel therapeutic targets. Endocrine therapies that either disrupt transactivation of ER or reduce the amount of ER present intracellularly are the core treatment strategies for ER-positive breast cancers, but intrinsic and acquired resistance limits clinical efficacy. 

Biological understanding of the different subtypes of breast cancer has revealed extraordinary insight into the heterogeneity within the disease, but it has also revealed fundamental processes associated with disease progression and treatment response. These recent advances in our understanding of breast cancer subtypes have resulted in tailored treatment for specific patient subpopulations and improved overall survival rates.

The development of newer treatments that target the ER pathway (i.e. CDK4/6 inhibitors that target a downstream target gene of the ER pathway) have changed breast cancer treatment. Recent analysis of cross-talk between ER and related nuclear receptor transcription factors, such as Androgen Receptor (AR), Progesterone Receptor (PR) and Glucocorticoid Receptor (GR) has identified novel therapeutic opportunities for blocking ER activity via activation of parallel, competing nuclear receptor pathways.

More recent developments in HER2-targeted agents for the treatment of HER2+ tumors have made substantial improvements to treatment responses for patients with HER2+ disease. Our understanding of Triple Negative Breast Cancer (TNBC) has generally lagged behind our understanding of other subtypes, but important recent new insight into the genetic perturbations and the associations with specific treatment responses have shed light on this subtype of the disease.

Transcriptomic and genetic studies have revolutionized our understanding of breast cancer and led to the development of new diagnostics and therapeutic strategies. More recent advances in single-cell RNA sequencing (scRNA-seq) and spatial imaging technologies have revolutionized our understanding of breast cancers and provided insight into complex cellular ecosystems that continuously interact with each other to govern tumor progression and treatment outcome.  New computational approaches have enabled the development of spatial maps of breast cancers at single-cell resolution, including immune cell populations and their interactions with stromal and tumor cells, providing unique biological and mechanistic insights into the tumour microenvironment and its role in disease progression, treatment-response and treatment-resistance.

This meeting will involve leaders in the field who study the biological basis of breast cancer, develop approaches for patient stratification, run clinical trials or develop new medicines for patients with breast cancer. 

Key Sessions

  • New molecular insight into breast cancer
  • Contemporary models of breast cancer
  • Spatial relationships between molecules and cell types
  • What are the molecular events that drive metastasis
  • Harnessing the immune system 
  • How do we position new treatments in the therapeutic spectrum

Early Career Researcher Grants

Due to the generous pledges from our invited speakers, we have been able to create several ECR grants. We currently have 8 x $1,000 registration grants set aside for early career researchers. If you are a student or postdoc (up to 6 years post higher degree), you are eligible. To apply please email the conference manager, Laura Trundle, with the following information; your career level, an abstract for talk or poster consideration and a short description as to why you would benefit from attending. Applications will be considered as they are submitted so although there is no application deadline, we recommend applying early to avoid disappointment as we only have a limited number of grants available. If you are interested in presenting a talk, please ensure your abstract and grant application are submitted no later than midnight GMT on Monday 06 February 2023.

Student & Postdoc Offer

Take advantage of this fantastic opportunity for students and postdocs! Fully paying academics can bring a student or postdoc for only $990. Both registration packages include; accommodation for the 01, 02, 03 May 2023 (on a shared basis for students/postdocs) and an all-inclusive food and beverage package for the conference period. Once registered, please contact Laura Trundle to obtain a special registration link for your student.

Confirmed Speakers

Cheryl Arrowsmith (University of Toronto)
Christine Chaffer (Garvan Institute of Medical Research)
Sarat Chandarlapaty (Memorial Sloan Kettering Cancer Center)
Melissa Davis (Walter and Eliza Hall Institute of Medical Research)
Geoffrey Greene (University of Chicago)
EFFECTIVE APPROACHES TO TARGETING MUTANT ER+ METASTATIC BREAST CANCER
Theresa Hickey (University of Adelaide)
ANDROGEN RECEPTOR SIGNALLING IN BREAST CANCER
Katherine Hoadley (University of North Carolina at Chapel Hill)
Walid Khaled (University of Cambridge)
Simon Knott (Cedars-Sinai)
Weibo Luo (University of Texas Southwestern Medical Center)
Mathieu Lupien (University Health Network)
Luca Magnani (Imperial College London)
Ciara Metcalfe (Genentech)
Bill Muller (McGill University)
Senthil Muthuswamy (National Cancer Institute)
Neal Rosen (Memorial Sloan Kettering Cancer Center)
Carol Sartorius (University of Colorado Anschutz Medical Campus)
Elinor Sawyers (King's College London)
Rachel Schiff (Baylor College of Medicine)
Violeta Serra (Vall d'Hebron Institute of Oncology)
Alex Swarbrick (Garvan Institute of Medical Research)
Valerie Weaver (University of California, San Francisco)
Leonie Young (Royal College of Surgeons in Ireland)
Wilbert Zwart (Netherlands Cancer Institute)

Target Audience

The audience will be a mixture of basic biologists, pre-clinical scientists, clinicians (including Oncologists, Pathologists, Surgeons), computational experts and representatives from Biotech and Pharma. While the audience will be composed of the world leaders in these fields, it will also be heavily focused towards trainees. We aim to attract excellent PhD students and postdocs from around the globe to expose them to the leaders in the field. As is typically the case for IABCR meetings, the audience will be composed of people from around the world, including North America, Europe and Australasia. We are particularly keen to bolster our attendance from regions that are typically under-represented, including South America and Asia and we will ensure that we invite a number of speakers from these regions. This will be facilitated financially (where possible) by travel awards for trainees from these specific regions to encourage attendance.

Education Need

New biological insight into the different breast cancer subtypes has revealed critical new information into ways of improving patient stratification (i.e. who should not receive specific treatments and who will likely benefit from those treatments), but the translation of these findings into better patient care requires collaborative efforts between basic biologists and clinicians. The IABCR meeting constitutes one of the premier meetings that brings together leading biologists and clinicians and the outcome of this is the sharing of knowledge that will steer pre-clinical work, based on the basic biological findings from attendees, as well as the initiation of clinical trials based on pre-clinical work presented at this meeting.

The ability to study breast cancer subtypes has been limited by the paucity of preclinical models representative of contemporary disease states (particularly for ER+ disease), the lack of robust genetic models and the fact that in vivo models to study breast cancer metastasis have been rudimentary and not physiologically relevant. These issues have been addressed by the community in recent years, with the advent of stable, well characterised PDX models of different subtypes, the implementation of organoid systems and the development and optimisation of the intraductal (MIND) model for studying breast cancer metastasis. These models and systems have been developed within specific labs, but for maximum exploitation and exposure of these new systems, the IABCR meeting is essential, since it will bring together key people developing the models, with researchers and doctors who can utilise them to address the most clinically relevant questions. The audience will learn about the value and utility of new in vitro, ex vivo and in vivo platforms, they will have the opportunity to discuss the nuances and technical specifics of these methods with the labs who have developed them, they will be exposed to new insight into molecular cross-talk and learn about the potential for single cell and spatial technologies to provide new insight into breast cancer progression and treatment response. The meeting will foster new collaborations between labs developing new models, labs with new technologies, and scientists and clinicians to develop new preclinical studies to address key biological questions and design clinical trials to better treat patients and improve survival of women with breast cancer.

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Speakers

Plenary Speakers

Neal Rosen

Memorial Sloan Kettering Cancer Center

Invited Speakers

Cheryl Arrowsmith

University of Toronto

Christine Chaffer

Garvan Institute of Medical Research

Sarat Chandarlapaty

Memorial Sloan Kettering Cancer Center

Melissa Davis

Walter and Eliza Hall Institute of Medical Research

Geoffrey Greene

University of Chicago

Theresa Hickey

University of Adelaide

Katherine Hoadley

University of North Carolina at Chapel Hill

Walid Khaled

University of Cambridge

Simon Knott

Cedars-Sinai

Weibo Luo

University of Texas Southwestern Medical Center

Mathieu Lupien

University Health Network

Luca Magnani

Imperial College London

Ciara Metcalfe

Genentech

Bill Muller

McGill University

Senthil Muthuswamy

National Cancer Institute

Carol Sartorius

University of Colorado Anschutz Medical Campus

Elinor Sawyers

King's College London

Rachel Schiff

Baylor College of Medicine

Violeta Serra

Vall d'Hebron Institute of Oncology

Alex Swarbrick

Garvan Institute of Medical Research

Leonie Young

Royal College of Surgeons in Ireland

Wilbert Zwart

Netherlands Cancer Institute

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Programme

We are hoping to organise a group trip prior to the conference commencing, if you wish to join we would encourage booking an extra night (Sunday 30th May) to ensure you can attend the trip. More information will be available soon.


Page: /

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Prices

Early Bird Full Price Additional Adult Additional Child Extra Night Adult Extra Night Child
Academic $1493 $1593 $566 $247 $279 $62
Industry $1493 $1593 $566 $247 $279 $62
Student $1187 $1287 $566 $247 $279 $62

All registration fees include 3 nights accommodation and meals during the conference period. Exact inclusions are detailed below.

What's Included in our Registration Fees?

Our registration fees are inclusive of the following at the Hilton Tulum Riviera Maya hotel during the conference period only:

- Conference registration 
- 3 nights’ fixed accommodation (01, 02, 03 May 2023) on a single basis for academics and industry, on a shared basis for students 
- Breakfast, lunch and dinner available at all restaurants according to their operational hours 
- Unlimited alcoholic beverages, cocktails and soft drinks available by the glass at all restaurants and bars according to their operational hours
- Gala Dinner 
- 24 hour room service
- Guest room mini bar (replenished daily)
- Complimentary WIFI in both conference rooms and your guest room

What's Included in our Accompanying Adult Fees?

Our accompanying adult fees are inclusive of the following at the Hilton Tulum Riviera Maya hotel during the conference period only:

- 3 nights’ fixed accommodation (01,02,03 May 2023) on a shared basis with a conference participant 
- Breakfast, lunch and dinner available at all restaurants according to their operational hours
- Unlimited alcoholic beverages, cocktails and soft drinks available by the glass at all restaurants and bars according to their operational hours
- Gala Dinner 
- 24 hour room service
- Guest room mini bar (replenished daily)
- Complimentary WIFI in your guest room

Important Note: Accompanying guests are not permitted access to the conference.

What's Included in our Accompanying Child Fees?

Our accompanying child fees are inclusive of the following at the Hilton Tulum Riviera Maya hotel during the conference period only:

- 3 nights’ fixed accommodation (01,02,03 May 2023) on a shared basis with the parent/s
- Breakfast, lunch and dinner available at all restaurants according to their operational hours
- Unlimited soft drinks available by the glass at all restaurants and bars according to their operational hours
- Gala Dinner 
- 24 hour room service
- Complimentary WIFI in your guest room

Important Note: Accompanying child fees are applicable for children aged 5-12 years. Children 4 years or younger stay free of charge with a parent. Children aged 13 years and older are classified as an adult at this venue (Hilton Tulum Riviera Maya). Please kindly ensure your child / children are supervised at all times during conference and related events. Childcare services are available at the hotel, please contact your conference manager for further information.

What's Included in our Extra Night Fees?

Our extra night fees are inclusive of the following at the Hilton Tulum Riviera Maya hotel:

- 1 night’s accommodation for 1 person
- Breakfast, lunch and dinner available at all restaurants according to their operational hours
- Unlimited alcoholic beverages, cocktails and soft drinks available by the glass at all restaurants and bars according to their operational hours
- 24 hour room service
- Guest room mini bar (replenished daily)
- Complimentary WIFI in your guest room

Important Note: Extra night child fees are applicable for children aged 5-12 years. Children 4 years or younger stay free of charge with a parent. Children aged 13 years and older are classified as an adult at this venue (Hilton Tulum Riviera Maya).

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

LinkedIn forum

Bringing together the global community of researchers and scientists interested in breast cancer research.

Relevant topics include research into the biological basis of breast cancer, patient stratification approaches, clinical trials and the development of new medicines for patients with breast cancer.

The group is open to all and is intended as a networking forum for past, present and future participants of Fusion Conferences as well as those interested in the related topics.

Join our group

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Venue

Hilton Tulum Riviera Maya

Venue Rating
Currency
US Dollar (USD)
Address
Carretera Cancun Tulum 307 Tulkal Chemuyil Tulum, 77774, Mexico
Nearest Airport
Cancun International Airport

We have wanted to contract with a property in the Riviera Maya for some time as it is a beautiful area of Mexico and has a very different vibe to the hustle and bustle of Cancun. Located just 8 miles from Tulum, this hidden gem is the perfect destination for those who love admiring, exploring or enjoying nature. Hilton Tulum Riviera Maya will captivate your senses with unparalleled natural views, bold flavors, clear blue skies, the gentle touch of the cool breeze and the irresistible aromas of this tropical paradise. We have a feeling this is going to be a new favourite amongst our delegates.

Hotel facilities include;

  • Complimentary Wi-Fi in guest rooms and throughout hotel and conference areas
  • Pools
  • Spa
  • Fitness Center
  • 9 Restaurants
  • Kids Club
  • Beach

Location

Stretching from the fishing village of Puerto Morelos to the biosphere reserve of Sian Ka'an, the Mayan Riviera offers an unforgettable Caribbean coastline experience with beautiful white-sand beaches and brilliant turquoise colored water. This world-renowned paradise is home to mangroves and lagoons, ancient Mayan cities, ecological reserves and adventure parks, and the world's second largest coral reef.

The hotel is located just a few miles from Tulum, a town on the Caribbean coastline of Mexico’s Yucatán Peninsula. It’s known for its spectacluar beaches and well-preserved ruins of an ancient Mayan port city. The area also offers incredible cavern diving opportunties and beautiful cenotes to explore. We would highly recommend joining one of the group activities to Tulum or the Gran Cenote - they will make for an unforgettable conference experience! 

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Transportation

Cancun International airport is approximately 1hr 15minutes from the Hilton Tulum Riviera Maya and is easily accessible from almost every country in the world with many major international airlines providing direct or interconnecting flights on a daily basis.

Airport transfer details and recommended suppliers will be available shorlty.

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Local Activities

Local activity details will be announced here soon. 

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Group Activities

Group activity details will be announced here soon

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Childcare

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Oral Presenters

We have several talk slots available at this meeting and we encourage students and ECR's to apply. To be considered for a talk, please register for the conference and upload your abstract when prompted to do so. You will be able to monitor the status of your abstract through your Fusion account and you will receive an email once a decision has been made. If your registration depends upon a succesul abstract submission, please email Laura Trundle and submit your abstract manually via email.

Please submit your abstract no later than mightnight GMT on Monday 06 February 2023.

Please use the abstract template provided (see below) and ensure your abstract is no longer than one page in length.

If you are accepted for a talk, we recommend you check our website regularly as the conference approaches. Regular programme updates will be released under the ‘Programme’ tab on the conference website.

If you require support to enable attendance, please select the 'Synopsis' tab on the left hand navigation panel to find out more information about our student/postdoc offer and ECR grants.

Your Presentation

On the day of your presentation please make yourself known to our AV technician who will be present in the conference room. We advise running through your presentation at least 30minutes prior to your session commencing to ensure your slides and any videos or animations appear as expected. We prefer our speakers to run their presentation from the master PC or Mac, however, if you prefer to use your own laptop then please notify us prior to the session. A HDMI or VGA cable is usually available on the podium.

Our AV technician will apply your microphone and provide a combined slide advancer and laser pointer.

We ask all speakers to adhere to their time slots and respect their fellow presenters. A visual traffic light aide will be available to warn presenters as their time decreases.

Please make sure your presentation adheres to the following guidelines.

Aspect Ratio: On Screen Show (16:9)

File Type: Please save your presentation in PPT, PPTS or Keynote format.

Download Abstract Template

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.

IABCR 2023: 32nd International Association for Breast Cancer Research Conference

#IABCR


01 May 2023 - 04 May 2023

Riviera Maya, Mexico

Chairs

Jason Carroll
University of Cambridge
Wayne Tilley
University of Adelaide

Posters

We have several poster opportunities available at this meeting. To be considered for a poster presentation, please register for the conference and upload your abstract when prompted to do so. You will be able to monitor the status of your abstract through your Fusion account and you will also receive an email once a decision has been made.

Please use the abstract template provided (see below) and ensure your abstract is no longer than one page in length.

Our poster boards can accommodate a maximum poster size of A0 (1189H x 841W mm), portrait in orientation. Posters exceeding this size may not fit on the poster boards provided and therefore we may be unable to display your poster, so please kindly keep to these measurements.

Displaying & Presenting Your Poster

Please bring your poster to registration and hand this to a member of the Fusion team. They will advise of your poster number and display your poster for you.

Your poster will remain on display for the duration of the conference, allowing presenters to take advantage of the refreshment breaks and free time for valuable networking opportunities, in addition to the official poster session.

Please check the programme and note the date and time of the poster session(s). Your poster will be judged during the poster session and prizes will be awarded at the Gala Dinner.

Posters will be taken down by the Fusion team and will be ready for collection at the Fusion desk on the final day of the conference.

Download Abstract Template

Supported By

Media Partners
If you're interested in sponsoring this conference please contact us.